Virtual screening of a library of commercially available compounds versus the structure of Mycobacterium tuberculosis lumazine synthase identified 2-(2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)acetic acid (9) as a possible lead compound. Compound 9 proved to be an effective inhibitor of M. tuberculosis lumazine synthase with a K(i) of 70microM. Lead optimization through replacement of the carboxymethylsulfonamide sidechain with sulfonamides substituted with alkyl phosphates led to a four-carbon phosphate 38 that displayed a moderate increase in enzyme inhibitory activity (K(i) 38microM). Molecular modeling based on known lumazine synthase/inhibitor crystal structures suggests that the main forces stabilizing the present benzindolone/enzyme complexes involve pi-pi stacking interactions with Trp27 and hydrogen bonding of the phosphates with Arg128, the backbone nitrogens of Gly85 and Gln86, and the side chain hydroxyl of Thr87. Copyright 2010 Elsevier Ltd. All rights reserved.
Virtual screening of a library of commercially available compounds versus the structure of Mycobacterium n class="Chemical">pan class="Disease">tuberculosis lumazine synthase identified class="Chemical">n>an class="Chemical">2-(2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)acetic acid (9) as a possible lead compound. Compound 9 proved to be an effective inhibitor of M. tuberculosis lumazine synthase with a K(i) of 70microM. Lead optimization through replacement of the carboxymethylsulfonamide sidechain with sulfonamides substituted with alkyl phosphates led to a four-carbon phosphate 38 that displayed a moderate increase in enzyme inhibitory activity (K(i) 38microM). Molecular modeling based on known lumazine synthase/inhibitor crystal structures suggests that the main forces stabilizing the present benzindolone/enzyme complexes involve pi-pi stacking interactions with Trp27 and hydrogen bonding of the phosphates with Arg128, the backbone nitrogens of Gly85 and Gln86, and the side chain hydroxyl of Thr87. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: I J Chen; N Neamati; M C Nicklaus; A Orr; L Anderson; J J Barchi; J A Kelley; Y Pommier; A D MacKerell Journal: Bioorg Med Chem Date: 2000-10 Impact factor: 3.641
Authors: Stefan Gerhardt; Ilka Haase; Stefan Steinbacher; Jens T Kaiser; Mark Cushman; Adelbert Bacher; Robert Huber; Markus Fischer Journal: J Mol Biol Date: 2002-05-17 Impact factor: 5.469
Authors: Christoph Scheich; Zoltán Szabadka; Beáta Vértessy; Vera Pütter; Vince Grolmusz; Markus Schade Journal: PLoS One Date: 2011-12-02 Impact factor: 3.240